uniQure NV (QURE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering uniQure NV.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
QURE's average price target has moved down $2.81999999999999 over the prior 117 days.
QURE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The number of analysts covering the stock of QURE is greater than 91.03% of all US stocks.
- QURE has a higher upside potential (average analyst target price relative to current price) than 95.17% of stocks in the mid market cap category.
- uniQure NV's variance in analysts' estimates is less than 13.7% of all US stocks.
- QURE has a greater average analyst price target than 86.22% of Pharmaceutical Products stocks.
- uniQure NV's NA is higher than practically none of all US stocks.
Is QURE a Buy, Hold or Sell? See the POWR Ratings now!